If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 640.00
Bid: 634.00
Ask: 640.00
Change: -5.00 (-0.78%)
Spread: 6.00 (0.946%)
Open: 640.00
High: 646.00
Low: 640.00
Prev. Close: 642.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

20 Mar 2024 18:31

RNS Number : 6881H
Intl. Biotechnology Trust PLC
20 March 2024
 

International Biotechnology: New Research

20/03/2024

Ailsa Craig and Marek Poszepczynski are celebrating their first three years as managers of IBT?

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPDEAAXLEFA
Date   Source Headline
23rd Jun 202310:33 amPRNNet Asset Value(s)
22nd Jun 202310:48 amPRNNet Asset Value(s)
22nd Jun 20238:00 amRNSPortfolio Update
21st Jun 20234:44 pmRNSTransaction in Own Shares
21st Jun 202310:30 amPRNNet Asset Value(s)
21st Jun 202310:11 amRNSDirector Declaration
20th Jun 20234:48 pmRNSTransaction in Own Shares
19th Jun 20235:32 pmRNSTransaction in Own Shares
15th Jun 20235:28 pmRNSTransaction in Own Shares
12th Jun 20235:02 pmRNSTransaction in Own Shares
8th Jun 20233:02 pmRNSDirector Declaration
5th Jun 20235:14 pmRNSTransaction in Own Shares
1st Jun 20239:28 amRNSTotal Voting Rights
31st May 20235:06 pmRNSTransaction in Own Shares
26th May 20235:19 pmRNSTransaction in Own Shares
25th May 20235:29 pmRNSTransaction in Own Shares
24th May 20235:08 pmRNSTransaction in Own Shares
23rd May 20235:02 pmRNSTransaction in Own Shares
19th May 20234:41 pmRNSTransaction in Own Shares
19th May 20238:00 amRNSPortfolio Update
18th May 20234:28 pmRNSTransaction in Own Shares
17th May 20235:13 pmRNSTransaction in Own Shares
16th May 20235:15 pmRNSTransaction in Own Shares
11th May 20235:35 pmRNSTransaction in Own Shares
10th May 20234:42 pmRNSTransaction in Own Shares
9th May 20235:16 pmRNSTransaction in Own Shares
4th May 20234:21 pmRNSTransaction in Own Shares
3rd May 20231:53 pmRNSResults analysis from Kepler Trust Intelligence
3rd May 20237:00 amRNSHalf Yearly Report
2nd May 20234:59 pmRNSTransaction in Own Shares
2nd May 20232:39 pmRNSDirector Declaration
2nd May 20239:10 amRNSTotal Voting Rights
28th Apr 202311:26 amPRNNet Asset Value(s)
28th Apr 202311:08 amPRNNet Asset Value(s)
28th Apr 202310:08 amPRNNet Asset Value(s)
26th Apr 20235:34 pmRNSTransaction in Own Shares
25th Apr 20238:00 amRNSPortfolio Update
21st Apr 20235:11 pmRNSTransaction in Own Shares
19th Apr 20235:16 pmRNSTransaction in Own Shares
17th Apr 20234:48 pmRNSTransaction in Own Shares
13th Apr 20235:09 pmRNSTransaction in Own Shares
12th Apr 20235:07 pmRNSTransaction in Own Shares
11th Apr 20234:52 pmRNSTransaction in Own Shares
6th Apr 20235:02 pmRNSTransaction in Own Shares
5th Apr 20234:58 pmRNSTransaction in Own Shares
4th Apr 20235:00 pmRNSTransaction in Own Shares
3rd Apr 20234:40 pmRNSTransaction in Own Shares
3rd Apr 20239:58 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSCompliance with the Market Abuse Regulation
31st Mar 20234:57 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.